Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DML6E6G)

Drug Name	Nomacopan DML6E6G
Drug Type	Recombinant protein

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Thrombotic microangiopathy	DISLZ0VW	3B65	Phase 3	[1]
Bullous pemphigoid	DISOJLKV	EB41.0	Phase 3	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT04784455) Multicentre Study of Nomacopan (rVA576) in Paediatric Haematopoietic Stem-Cell Transplant Associated Thrombotic Microangiopathy. U.S.National Institutes of Health.
2	ClinicalTrials.gov (NCT05061771) A Randomized, Part A Partial Blinded and Part B Double Blinded, Placebo-controlled 24-week Clinical Study to Evaluate the Efficacy and Safety of Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP). U.S.National Institutes of Health.